Original ArticleNocturnal sleep, daytime sleepiness and fatigue in fibromyalgia patients compared to rheumatoid arthritis patients and healthy controls: A preliminary study
Introduction
The first polysomnographic (PSG) study of fibromyalgia (FM) was performed in 1975 [1]. This early PSG study of FM reported intrusions of EEG alpha activity (α-EEG) in NREM sleep, which correlated positively with pain scores. This data led to the speculation that α-EEG is a marker of the musculoskeletal pain and mood symptoms of FM. Subsequently, there have been multiple reports indicating a correlation between α-EEG and FM pain [2], [3], [4], [5]. While FM continues to be characterized by sleep disturbance and pain, the causal link between α-EEG and FM symptoms has not been substantiated. The presence and amount α-EEG is difficult to assess and quantify visually and the procedures and scoring rules for its visual assessment have yet to be established [6], [7]. Automated, fast Fourier transform computer analyses of α-EEG is also not without controversy [8]. Furthermore, the α-EEG NREM sleep anomaly is reported in other patient populations, as well as healthy controls (HC) [9], [10], [11], [12], [13]. In fact, some have argued that the non-specificity of the α-EEG marker is because α-EEG is a characteristic of sleep maintenance rather than disturbance [8], [9], [10], [11], [12], [13], [14].
Beyond the α-EEG anomaly, FM patients also have significantly longer sleep latencies than healthy controls (HC) [12]. They often have increased arousals and a greater number of transitions from one sleep stage to another [15] and lower amounts of slow wave sleep (corrected for age), REM, and total sleep time (TST) [16]. Shorter durations of stage 2 NREM sleep have also been reported, compared to healthy controls (HC) [17]. FM patients often report insomnia symptoms [2], [4], [18] and their reports of not getting enough sleep, disturbed sleep, and waking less rested are more frequent than in HC. Interestingly, they have better recall of their awakenings than controls [3].
Similar to FM, rheumatoid arthritis (RA) patients experience sleep disturbance and pain [7]. However, the sleep disturbance of RA has been characterized by fragmented sleep and increased wake caused by discrete, short arousals [19], [20]. RA patients were also found to have multiple stage shifts and a higher occurrence as compared to HC of periodic leg movements, which also fragment sleep. [21], [19]. Patients with RA often report daytime sleepiness and fatigue in association with their pain [22]. The Level of fatigue is an important symptom as it has been shown to correlate with dysfunction [23]. A recent study of RA showed that poor sleep quality was significantly correlated with mood disturbance, pain, fatigue and functional disability [24]. Studies of RA patients have also shown that hypnotic treatment (triazolam) of sleep disturbance can lead to a reduction in morning stiffness and daytime sleepiness [25]. In contrast, similar hypnotic treatment (zopiclone) only improves “tiredness” in FM patients [26].
FM is thought of to involve heightened sensitivity of all, in addition to pain, central nervous system sensory processing, or in abnormalities of the endocrine system [16], whereas RA is more frequently attributed to peripheral nervous system and immune system dysfunction [7]. The pain of FM is considered to be widespread involving all soft tissues [16], while that of RA is localized to the joints and surrounding tissue [7]. The similarity of symptoms, despite the difference between relative central and peripheral involvement and localization of pain in these two disorders, makes them valuable to compare to further understand the relation of nocturnal sleep to daytime sleepiness, fatigue and pain. The authors of a literature review on sleep in RA argued that current studies of chronic rheumatoid diseases are inconsistent in their findings and they encouraged the further systematic, objective study of sleep and daytime function [22].
We report on the relation between self-report measures and objective measures of nocturnal sleep (PSG) and daytime sleepiness (MSLT), as well as self-reported fatigue and pain in these two pain disorders. We compared the two pain disorders to each other and to healthy age and gender matched controls. Symptoms of sleepiness, fatigue, and pain are commonly reported in both disorders and are associated with reports of disturbed and non-refreshing sleep. To our knowledge, no studies have compared objective measures of the sleep of FM to RA patients directly. In addition, there are no studies that have compared patients’ subjective and objective measures of sleepiness, as well as attempted to distinguish sleepiness from fatigue in these pain disorders.
Section snippets
Participants
Participants were 50 women from southeastern Michigan who were recruited from local newspapers and physician referrals: 18 with FM, 16 with RA, and 16 healthy controls (HC) age-matched to the patients. Participants in the two pain groups were required to (a) have FM or RA as their primary pain condition (see below for the diagnostic procedures); (b) report a customary bedtime of midnight or earlier; and (c) report current pain severity of at least 4 on a scale of 1–10. Individuals were excluded
Baseline group comparisons
Table 2 presents the self-report measures at baseline, before and after sleep, and the following day during the MSLT for the three groups. Analyses revealed no significant differences among the FM, RA, and HC groups in baseline sleepiness on the ESS (F = 2.06, p = 0.14). No group showed mean ESS scores indicative of excessive daytime sleepiness. In contrast, analyses revealed significant differences between the groups for baseline fatigue severity on the FAI (F = 31.72, p < 0.001). Post hoc tests
Discussion
This is the first study comparing FM and RA patients to each other and to HC on objective and subjective measures of sleep, daytime sleepiness, fatigue and pain. Two major findings of this study stand out: (1) the unusually high MSLT scores, that is high alertness of FM patients relative to RA patients despite a comparable degree of disturbed nocturnal sleep and (2) the absence of a correlation between self-ratings of sleepiness and the objective MSLT measure of sleepiness in the FM group.
Limitations
This study has several limitations. First, the sample size for the three groups were relatively small and larger samples may have yielded clearer differences, particularly between FM and RA patients. Second, the samples studied were free of a host of potential confounds, such as depression, other psychiatric disorders, substance use, and many medications, including antidepressants, that can alter sleep parameters. Although eliminating these confounds is a strength of this study and enhances the
Conflict of Interest
The ICMJE Uniform Disclosure Form for Potential Conflicts of Interest associated with this article can be viewed by clicking on the following link: http://dx.doi.org/10.1016/j.sleep.2012.09.020.
Acknowledgement
Supported by an Arthritis Foundation Grant awarded to Dr. M. Gillis.
References (42)
- et al.
Musculoskeletal symptoms and non-REM sleep disturbances in patients with “fibrositis syndrome” and healthy subjects
Psychosom Med
(1975) - et al.
Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome)
Psychosom Med
(1986) - et al.
Sleep physiology and pcychological aspects of fibrositis (fibromyalgia) syndrome
Can J Psychiatry
(1991) - et al.
Sleep cycles and alpha–delta sleep in fibromyalgia syndrome
J Rheumatol
(1994) - et al.
Alpha sleep and information processing, perception of sleep and information processing, perception of sleep, pain and arousability in fibromyalgia
Int J Neurosci
(1997) - et al.
Limitations of Rechtschaffen and Kales
Sleep Med Rev
(2000) Pain and sleep disturbances with special reference to fibromyalgia and rheumatoid arthritis
Rheumatology
(1999)- et al.
A reconceptualization of EEG alpha activity as an index of arousal during sleep: all alpha activity is not equal
J Sleep Res
(1995) - et al.
Alpha–delta sleep
Electroenceph Clin Neurophysiol
(1973) - et al.
Sleep, its subjective perception and daytime performance in insomniacs with a pattern of alpha sleep
Soc Bio Psychiatry
(1995)
Sleep and chronic pain: challenges to the α-EEG sleep pattern as a pain specific sleep anomaly
J Psychosom Res
Alpha-like EEG activity in non-REM sleep and the fibromyalgia (fibrositis) syndrome
Electoenceph Clin Neurophysiol
Alpha sleep characteristics in fibromyalgia
Arthritis Rheum
The α-sleep pattern-quantitative analysis and functional aspects
Sleep and other symptoms in primary fibrolmyalgia syndrome and healthy controls
J Rheum
Sleep in fibromyalgia and chronic pain
Sleep stage dynamics in fibromyalgia patients and controls
Sleep Med
Sleep and circadian rhythm disorders in fibromyalgia
Curr Rheumatol Rep
Objective and subjective sleep disturbances in patients with rheumatoid arthritis
Arthritis Rheum
Nonsteroidal anti-inflammatory drug therapy in rheumatoid arthritis patients: lack of association between clinical improvement and effects on sleep
Arthritis Rheum
Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of sleep/wake interactions
Brit J Rheumatol
Cited by (52)
Assessment of fatigue and functional impairment in patients with rheumatic diseases
2020, Egyptian RheumatologistCitation Excerpt :In SLE, Fronseca et al. [33] detected significantly higher fatigue scores and lower QoL. FM patients had greater fatigue than healthy controls [34]. Ates et al. showed that fatigue and worse QoL are prevalent in AS [35].
Can rheumatoid arthritis affect sleep in Egyptian patients?
2018, Egyptian RheumatologistSleep disturbances in fibromyalgiaA meta-analysis of case-control studies
2017, Journal of Psychosomatic ResearchWhat resources do people with persistent pain use to help them better understand their pain? A cross-sectional survey
2024, Health Education Journal